HomeMIRM • BMV
add
Mirum Pharmaceuticals Inc
Previous close
$1,865.01
Year range
$755.20 - $1,817.43
Market cap
5.57B USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 148.93M | 49.81% |
Operating expense | 125.24M | 24.17% |
Net income | -5.73M | 75.91% |
Net profit margin | -3.85 | 83.91% |
Earnings per share | -0.12 | 75.51% |
EBITDA | — | — |
Effective tax rate | -15.45% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 383.33M | 36.75% |
Total assets | 842.81M | 25.65% |
Total liabilities | 528.12M | 18.65% |
Total equity | 314.69M | — |
Shares outstanding | 60.34M | — |
Price to book | 307.76 | — |
Return on assets | -1.40% | — |
Return on capital | -1.83% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.73M | 75.91% |
Cash from operations | 6.07M | 219.71% |
Cash from investing | 1.01M | 56.94% |
Cash from financing | 9.00M | 68.52% |
Net change in cash | 15.66M | 3,461.37% |
Free cash flow | 53.84M | 1,945.26% |
About
Founded
2018
Headquarters
Website
Employees
369
